The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
Open Access
- 19 March 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 193
- https://doi.org/10.3389/fphar.2020.00193
Abstract
Cancer is a common malignant disease worldwide with an increasing mortality in recent years. Salvia miltiorrhiza, a well-known traditional Chinese medicine, has been used for the treatment of cardiovascular and cerebrovascular diseases for thousands of years. The liposoluble tanshinones in S. miltiorrhiza are important bioactive components and mainly include tanshinone IIA, dihydrodanshinone, tanshinone I, and cryptotanshinone. Previous studies showed that these four tanshinones exhibited distinct inhibitory effects on tumor cells through different molecular mechanisms in vitro and in vivo. The mechanisms mainly include the inhibition of tumor cell growth, metastasis, invasion, and angiogenesis, apoptosis induction, cell autophagy, and antitumor immunity, and so on. In this review, we describe the latest progress on the antitumor functions and mechanisms of these four tanshinones to provide a deeper understanding of the efficacy. In addition, the important role of tumor immunology is also reviewed.Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China
- Shanghai Municipal Education Commission
This publication has 155 references indexed in Scilit:
- Comparative Oncogenomic Analysis of Copy Number Alterations in Human and Zebrafish Tumors Enables Cancer Driver DiscoveryPLoS Genetics, 2013
- Forkhead Box M1 (FoxM1) Gene Is a New STAT3 Transcriptional Factor Target and Is Essential for Proliferation, Survival and DNA Repair of K562 Cell LinePLOS ONE, 2012
- Tanshinones: Sources, Pharmacokinetics and Anti-Cancer ActivitiesInternational Journal of Molecular Sciences, 2012
- Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic modelOncogene, 2012
- The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cellsThe Prostate, 2012
- Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65Molecular Medicine Reports, 2012
- Human Endothelial Progenitor CellsCold Spring Harbor Perspectives in Medicine, 2011
- A Functional Genomics Approach to Tanshinone Biosynthesis Provides Stereochemical InsightsOrganic Letters, 2009
- Altered macrophage differentiation and immune dysfunction in tumor developmentJCI Insight, 2007
- Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitroExperimental & Molecular Medicine, 2005